1.
J Viral Hepat
; 27(9): 955-958, 2020 09.
Artículo
en Inglés
| MEDLINE
| ID: mdl-32347645
RESUMEN
Direct-acting antivirals (DAAs) for HCV treatment have improved tolerance and efficacy among adults, but experience in vertical transmission is scarce. In our vertically HIV/HCV co-infected youth cohort of 58 patients, DAA achieved excellent rates of cure among naïve and pretreated individuals. Treating vertically infected seems important as 29.6% displayed advanced fibrosis at treatment initiation.